Eledon Pharmaceuticals, Inc. (ELDN)
Nasdaq: ELDN · CIK 0001404281 · United States
Every official Eledon Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ELDN filings
Eledon Pharmaceuticals, Inc. documents
- Eledon Pharmaceuticals, Inc. 10-K 2026ELDN 10-K 2026: annual report for fiscal 2026
- Eledon Pharmaceuticals, Inc. 10-K 2025ELDN 10-K 2025: annual report for fiscal 2025
- Eledon Pharmaceuticals, Inc. 10-K 2024ELDN 10-K 2024: annual report for fiscal 2024
- Eledon Pharmaceuticals, Inc. 10-K 2023ELDN 10-K 2023: annual report for fiscal 2023
- Eledon Pharmaceuticals, Inc. 10-K 2022ELDN 10-K 2022: annual report for fiscal 2022
- Eledon Pharmaceuticals, Inc. 10-Q 2026ELDN 10-Q 2026: quarterly report for fiscal 2026
- Eledon Pharmaceuticals, Inc. 10-Q 2025ELDN 10-Q 2025: quarterly report for fiscal 2025
- Eledon Pharmaceuticals, Inc. 10-Q 2024ELDN 10-Q 2024: quarterly report for fiscal 2024
- Eledon Pharmaceuticals, Inc. 10-Q 2023ELDN 10-Q 2023: quarterly report for fiscal 2023
- Eledon Pharmaceuticals, Inc. 10-Q 2022ELDN 10-Q 2022: quarterly report for fiscal 2022
- Eledon Pharmaceuticals, Inc. 8-K 2026ELDN 8-K 2026: current report for fiscal 2026
- Eledon Pharmaceuticals, Inc. 8-K 2025ELDN 8-K 2025: current report for fiscal 2025
- Eledon Pharmaceuticals, Inc. 8-K 2024ELDN 8-K 2024: current report for fiscal 2024
- Eledon Pharmaceuticals, Inc. 8-K 2023ELDN 8-K 2023: current report for fiscal 2023
- Eledon Pharmaceuticals, Inc. 8-K 2022ELDN 8-K 2022: current report for fiscal 2022
- Eledon Pharmaceuticals, Inc. DEF 14A 2026ELDN DEF 14A 2026: proxy statement for fiscal 2026
- Eledon Pharmaceuticals, Inc. DEF 14A 2025ELDN DEF 14A 2025: proxy statement for fiscal 2025
- Eledon Pharmaceuticals, Inc. DEF 14A 2024ELDN DEF 14A 2024: proxy statement for fiscal 2024
- Eledon Pharmaceuticals, Inc. DEF 14A 2023ELDN DEF 14A 2023: proxy statement for fiscal 2023
- Eledon Pharmaceuticals, Inc. DEF 14A 2022ELDN DEF 14A 2022: proxy statement for fiscal 2022
- Eledon Pharmaceuticals, Inc. Form 4 2026ELDN Form 4 2026: insider trading filing for fiscal 2026
- Eledon Pharmaceuticals, Inc. Form 4 2025ELDN Form 4 2025: insider trading filing for fiscal 2025
- Eledon Pharmaceuticals, Inc. Form 4 2024ELDN Form 4 2024: insider trading filing for fiscal 2024
- Eledon Pharmaceuticals, Inc. Form 4 2023ELDN Form 4 2023: insider trading filing for fiscal 2023
- Eledon Pharmaceuticals, Inc. Form 4 2022ELDN Form 4 2022: insider trading filing for fiscal 2022
- Eledon Pharmaceuticals, Inc. S-1 2026ELDN S-1 2026: registration statement for fiscal 2026
- Eledon Pharmaceuticals, Inc. S-1 2025ELDN S-1 2025: registration statement for fiscal 2025
- Eledon Pharmaceuticals, Inc. S-1 2024ELDN S-1 2024: registration statement for fiscal 2024
- Eledon Pharmaceuticals, Inc. S-1 2023ELDN S-1 2023: registration statement for fiscal 2023
- Eledon Pharmaceuticals, Inc. S-1 2022ELDN S-1 2022: registration statement for fiscal 2022
- Eledon Pharmaceuticals, Inc. 13F 2026ELDN 13F 2026: institutional holdings for fiscal 2026
- Eledon Pharmaceuticals, Inc. 13F 2025ELDN 13F 2025: institutional holdings for fiscal 2025
- Eledon Pharmaceuticals, Inc. 13F 2024ELDN 13F 2024: institutional holdings for fiscal 2024
- Eledon Pharmaceuticals, Inc. 13F 2023ELDN 13F 2023: institutional holdings for fiscal 2023
- Eledon Pharmaceuticals, Inc. 13F 2022ELDN 13F 2022: institutional holdings for fiscal 2022
More companies